Immix Biopharma, Inc.
IMMX
$1.99
-$0.42-17.43%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 13.62% | 5.45% | -67.01% | -22.84% | -112.08% |
| Total Depreciation and Amortization | 147.70% | 1,232.26% | 1,750.00% | 4,760.00% | 4,680.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -0.32% | -28.35% | 8.86% | 46.79% | 179.59% |
| Change in Net Operating Assets | 259.30% | 81.80% | 353.92% | -313.99% | 610.45% |
| Cash from Operations | 55.97% | 44.86% | -30.76% | -49.52% | -82.93% |
| Capital Expenditure | 77.58% | -3,742.42% | -597.94% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 77.58% | -3,742.42% | -597.94% | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -100.00% | -100.00% | -100.00% | 15,249.95% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -100.00% | -100.00% | -100.00% | 13,313.46% |
| Foreign Exchange rate Adjustments | 23.08% | -180.19% | 294.92% | -36.88% | -1,633.33% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -114.91% | 3.09% | -161.84% | -548.90% | 698.37% |